In an age when Bharat’s spirit of innovation is shaping the world’s future, Superceuticals is turning healthcare equity from aspiration into action. Founded by Rrachnna Singh, a purpose-driven entrepreneur with a firm belief in tech-led public good, Superceuticals carries a single, uncompromising mission — to standardise healthcare across urban and rural India and beyond, ensuring that world-class diagnostics and preventive care are no longer privileges, but guarantees.
Secret of Success
At the heart of this mission lies the SC-AN series — a hardware-software-AI integrated diagnostic system available in both static and mobile models. SC-AN delivers laboratory-grade results across 120+ parameters — including blood panels, cardiac and diabetic profiles, hormonal markers, and infectious disease detection — within 15 minutes, even in rural and small-town settings.
Superceuticals is providing faster diagnostics. By deploying SC-AN at villages, districts and States, the company is creating a new culture of healthcare, where people expect reliable, high-quality results delivered quickly, and where waiting for days is no longer tolerated. This shift is critical in tier-2, tier-3 cities and rural areas, where delayed diagnoses have historically cost lives.
The biggest challenge wasn’t technology — it was changing mindsets and healthcare habits. In rural areas, people were used to delayed results, inconsistent testing, and fragmented services. Superceuticals had to instil confidence that rapid, standardised diagnostics are now possible. Through consistent performance and demonstrable reliability, SC-AN is rewriting what patients expect, creating a habit of timely, trustworthy diagnostics.
Superceuticals is privately held, with strong interest from both Ihealthcare and technology investors. It is a combination of hardware robustness, software intelligence, and AI support makes it uniquely positioned to scale rapid, standardised diagnostics across India.
Domestic deployments include Madhya Pradesh, Uttar Pradesh, Assam and Sikkim, along with institutional partners such as the Indian Army and TAPS. Superceuticals is exploring exports to South East Asia and Africa, regions facing similar gaps in rapid, standardised healthcare delivery.
